The 4th study of prophylactic intravesical chemotherapy with Adriamycin in the treatment of superficial bladder cancer: the experience of the Japanese urological cancer research group of Adriamycin
โ Scribed by Yosuke Matsumura; Hideyuki Akaza; Shigeo Isaka; Susumu Kagawa; Kenkichi Koiso; Toshihiko Kotake; Toyohei Machida; Tadao Niijima; Koji Obata; Yasuo Ohashi; Hiroshi Ohe; Yoshitada Ohi; Jun Shimazaki; Kazuya Tashiro; Toyofumi Ueda
- Publisher
- Springer
- Year
- 1992
- Tongue
- English
- Weight
- 397 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Patients with advanced breast cancer who had not previously received chemotherapy were treated on a three-arm prospective study: adriamycin day 1 plus 5-FU on day 1 and 8 (AF), adriamycin day 1 , plus 5-FU day 1 and 8 , and cyclophosphamide day 1 (AFC), and adriamycin day 1 plus 5-FU day 1 and 8 , c
## BACKGROUND. The effect of intravesical instillation of doxorubicin or epirubicin after transurethral resection (TUR) was estimated from the data of five randomized clinical trials in Japan. The authors provided the estimated hazard function plots with a smoothing technique, to evaluate the prop